NJ A3621 | 2024-2025 | Regular Session
Note: Carry Over of previous A2240
Note: Carry Over of previous S1667
Note: Carry Over of previous S1667
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 12 2024 - 25% progression
Action: 2024-02-12 - Introduced, Referred to Assembly Health Committee
Pending: Assembly Health Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on February 12 2024 - 25% progression
Action: 2024-02-12 - Introduced, Referred to Assembly Health Committee
Pending: Assembly Health Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.
Title
Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2024-02-12 | Assembly | Introduced, Referred to Assembly Health Committee |
Same As/Similar To
A2240 (Carry Over) 2022-02-07 - Introduced, Referred to Assembly Health Committee
S1667 (Carry Over) 2022-02-14 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
S1667 (Carry Over) 2022-02-14 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
Subjects
New Jersey State Sources
| Type | Source |
|---|---|
| Summary | https://www.njleg.state.nj.us/bill-search/2024/A3621 |
| Text | https://pub.njleg.gov/Bills/2024/A4000/3621_I1.HTM |
